Pennant Group, Inc. (The) (PNTG)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · PNTG
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Entry into a Material Definitive Agreement. On November 3, 2025, The Pennant Group, Inc. (the “Company”), entered into that certain First Amendment to Amended and Restated Credit Agreement (the “First Amendment”) with Truist Bank, as administrative agent, and certain banks as additional lenders, which amends the Company’s existing Amended and Restated Credit Agreement, dated as of July 31, 2024 (as amended by the First Amendment, the “Credit Facility”). Pursuant to the First Amendment, the Co…
and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Creation of a Direction Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant. The disclosure of the First Amendment contained in
Entry into a Material Definitive Agreement. On October 1, 2025, The Pennant Group, Inc. (the “Company”), as a guarantor, its wholly-owned subsidiaries, Cornerstone Healthcare, Inc. (“Entity Buyer”) and Tensaw River Healthcare LLC (“Asset Buyer”), and UnitedHealth Group Incorporated (“UnitedHealth”), Amedisys, Inc. (“Amedisys”) and certain other sellers (collectively with UnitedHealth and Amedisys, the “Sellers”), entered into a First Amendment (the “Amendment”) to that certain Purchase Agreem…
Completion of Acquisition or Disposition of Assets. On October 1, 2025, The Pennant Group, Inc. (the “Company”) consummated the previously announced acquisitions contemplated by that certain Purchase Agreement (the “Purchase Agreement”), dated April 30, 2025, as amended by the First Amendment to Purchase Agreement dated October 1, 2025 (the “Amendment”), by and among the Company, its wholly-owned subsidiaries, Cornerstone Healthcare, Inc. (“Equity Buyer”) and Tensaw River Healthcare LLC (“Ass…
and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Entry into a Material Definitive Agreement. On April 30, 2025, The Pennant Group, Inc. (the “Company”), through its wholly-owned subsidiaries, Cornerstone Healthcare, Inc. (“Entity Buyer”) and Tensaw River Healthcare LLC (“Asset Buyer”), entered into a Purchase Agreement (the “Purchase Agreement”) with UnitedHealth Group Incorporated (“UnitedHealth”), Amedisys, Inc. (“Amedisys”) and certain other sellers (collectively, the “Sellers”). Pursuant to the Purchase Agreement, Entity Buyer will acqu…
and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Other Events. On January 1, 2025, Cornerstone Healthcare, Inc., a wholly-owned subsidiary of The Pennant Group, Inc., completed the purchase of the Signature Healthcare at Home (“Signature”) assets previously identified and announced in the Company’s current report on Form 8-K dated July 11, 2024. The acquisition was consummated through two separate agreements to purchase certain of the home health and hospice operating assets of Signature in Idaho, Oregon, and Washington (the “Purchase Agree…
Results of Operations and Financial Condition. On November 6, 2024 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its third quarter ended September 30, 2024. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Entry into a Material Definitive Agreement. On October 2, 2024, The Pennant Group, Inc. (the “Company”) closed the public offering (the “Offering”) of 4,025,000 shares of its common stock, $0.001 par value per share (“common stock”). In connection with the Offering, the Company entered into an underwriting agreement, dated as of October 2, 2024 (the “Underwriting Agreement”), with Citigroup Global Markets Inc. and Truist Securities, Inc., as representatives of the several underwriters named t…
Results of Operations and Financial Condition. On August 6, 2024 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its second quarter ended June 30, 2024. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Creation of a Direction Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant. The disclosure of the Credit Agreement contained in
Entry into a Material Definitive Agreement. On July 31, 2024, The Pennant Group, Inc. (“Pennant” or the “Company”) entered into an Amended and Restated Credit Agreement (the “Credit Facility”) with Truist Bank, as administrative agent, and certain banks as additional lenders. The Credit Facility increases Pennant’s existing credit facility by $100.0 million to an aggregate principal amount of up to $250.0 million and extends the maturity date to July 31, 2029. The interest rates applicable to…
Results of Operations and Financial Condition. On May 6, 2024 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its first quarter ended March 31, 2024. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Results of Operations and Financial Condition. On February 28, 2024 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its fourth quarter ended December 31, 2023. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Results of Operations and Financial Condition. On November 7, 2023 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its third quarter ended September 30, 2023. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Results of Operations and Financial Condition. On August 8, 2023 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its second quarter ended June 30, 2023. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant. The disclosure of the Credit Agreement contained in
Entry into a Material Definitive Agreement. On June 12, 2023 The Pennant Group, Inc. (“Pennant” or the “Company”) entered into the Second Amendment to Credit Agreement (the “Amendment”) with Truist Bank as administrative agent and certain banks as additional lenders. The Amendment amends the Company’s credit agreement originally entered into as of October 1, 2019 (filed as Exhibit 10.1 to the Company’s Form 8-K dated February 24, 2021 (the “Credit Agreement”), as amended by the First Amendmen…
Chief Financial Officer — Lynette B. Walbom: Ms. Lynette B. Walbom was appointed as the Chief Financial Officer, replacing Ms. Jennifer L. Freeman.
Importance-ranked changes since the prior daily snapshot.
Signal changed from 'mild_favorable' to 'mixed'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.